Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy

The New England Journal of Medicine
William KrivitLawrence A Lockman

Abstract

Globoid-cell leukodystrophy is caused by a deficiency of galactocerebrosidase, which results in progressive central nervous system deterioration. We investigated whether allogeneic hematopoietic stem-cell transplantation can provide a source of leukocyte galactocerebrosidase and thereby prevent the decline of central nervous system function in patients with the disease. Five children with globoid-cell leukodystrophy (one with the infantile type and four with late-onset disease) were treated with allogeneic hematopoietic stem-cell transplantation. Measurement of leukocyte galactocerebrosidase levels, neurologic examinations, neuropsychological tests, magnetic resonance imaging of the central nervous system, cerebrospinal fluid protein assays, and neurophysiologic measurements were performed before and after transplantation, with follow-up ranging from one to nine years. Engraftment of donor-derived hematopoietic cells occurred in all patients and was followed by restoration of normal leukocyte galactocerebrosidase levels. In the four patients with late-onset disease, the central nervous system deterioration was reversed, and in the patient with the infantile form of the disease, signs and symptoms have not appeared. Magnetic res...Continue Reading

References

Apr 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·M PhelpsM T Vanier
Sep 1, 1990·Ophthalmology·R H BakerD Zimmerman
Jan 1, 1995·Journal of Inherited Metabolic Disease·E G ShapiroW Krivit
Jul 1, 1994·Journal of Neuropathology and Experimental Neurology·K Suzuki
Oct 15, 1995·Microscopy Research and Technique·K Suzuki, M Taniike
Jul 18, 1996·The New England Journal of Medicine·J KurtzbergP Rubinstein
Feb 2, 1997·Bone Marrow Transplantation·B J BambachR J Jones
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A Eglitis, E Mezey

❮ Previous
Next ❯

Citations

Jun 10, 2006·Journal of Inherited Metabolic Disease·Jaap Jan Boelens
Mar 18, 2008·Journal of Inherited Metabolic Disease·F SedelO Lyon-Caen
Dec 23, 2011·Journal of Inherited Metabolic Disease·Lainie Friedman Ross
Apr 3, 2001·Current Treatment Options in Neurology·Edward M. Kaye
Apr 12, 2011·International Journal of Hematology·Hiroshi YagasakiHideo Mugishima
Oct 8, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ian D DuncanSu-Chun Zhang
Dec 20, 2003·Pediatric Neurology·J Jeffrey MalatackEliel Bayever
Jun 15, 1999·Brain Research. Developmental Brain Research·P RezaieD K Male
Dec 29, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·C Caillaud, L Poenaru
Feb 22, 2001·Pediatric Neurology·E M Kaye
Nov 14, 2000·Molecular Medicine Today·D A Wenger
Nov 13, 2008·Cytotechnology·Patrizia TuniciGaetano Finocchiaro
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Darshong LinMark S Sands
Jul 15, 2000·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·D V SurbekW Holzgreve
Feb 11, 2011·The New England Journal of Medicine·Paul J Orchard, John E Wagner
May 20, 2005·The New England Journal of Medicine·Kenneth I Weinberg
May 20, 2005·The New England Journal of Medicine·Maria L EscolarJoanne Kurtzberg
Sep 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Raquel L Lieberman
Apr 5, 2011·Human Molecular Genetics·Alessandra BiffiNathalie Cartier
Apr 7, 2007·Topics in Magnetic Resonance Imaging : TMRI·Michael J J KimMeng Law
Apr 20, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Raymond Y WangUNKNOWN ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases
Nov 11, 2009·The Neurologist·Daniel J CostelloFlorian S Eichler
Mar 3, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Brandi K OrmerodMaeve A Caldwell
Apr 16, 2004·The Journal of Clinical Investigation·Richard L Proia, Yun-Ping Wu
Feb 18, 1999·The Journal of Clinical Investigation·Y LiuR L Proia
Nov 9, 2011·Orphanet Journal of Rare Diseases·Maurizio ScarpaUNKNOWN Hunter Syndrome Europena Expert Council
Apr 4, 2002·Drugs·Raphael Schiffmann, Roscoe O Brady
Dec 23, 2008·AJR. American Journal of Roentgenology·James M ProvenzaleMaria Escolar
May 12, 2010·Regenerative Medicine·Kevin KempAlastair Wilkins
Mar 18, 2008·Neurosurgical Focus·Gregory M Enns, Stephen L Huhn
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·D W Kennedy, J L Abkowitz
Dec 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yoichi KondoIan D Duncan
Mar 5, 2011·Acta Neuropathologica·Ludovico Cantuti CastelvetriErnesto Roque Bongarzone
May 27, 2014·Brain Research·Donald G Phinney, Iryna A Isakova
Sep 28, 2014·Gene·Adriana Carol Eleonora Graziano, Venera Cardile

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.